TMO Earnings & Financial Statements
Thermo Fisher Scientific Inc.
$673.20
+$10.16(+1.53%)
67
Overall
75
Value
66
Tech
60
Quality
Market Cap
$248.91B
Volume
2.48M
52W Range
$435.27 - $694.33
Target Price
$667.08
TMO earnings and financial statements: Thermo Fisher Scientific Inc.'s income statement, balance sheet and cash flow statement, annual and quarterly.
TMO Annual Financial Statements
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | $44.56B | $42.88B | $42.86B | $44.91B | $39.21B |
| Cost of revenue | $26.32B | $25.18B | $25.76B | $25.94B | $19.57B |
| Operating income | $7.75B | $7.34B | $6.86B | $8.39B | $10.03B |
| EBITDA | $11.47B | $11.49B | $11.02B | $11.77B | $11.97B |
| Net income | $6.70B | $6.33B | $6.00B | $6.95B | $7.72B |
| EPS (diluted) | $17.74 | $16.53 | $15.45 | $17.63 | $19.46 |
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total assets | $110.34B | $97.32B | $98.73B | $97.15B | $95.12B |
| Total liabilities | $56.81B | $47.65B | $51.88B | $53.01B | $54.15B |
| Shareholders’ equity | $53.41B | $49.58B | $46.73B | $43.98B | $40.79B |
| Cash and equivalents | $9.85B | $4.01B | $8.08B | $8.52B | $4.48B |
| Long-term debt | $35.85B | $29.06B | $31.31B | $28.91B | $32.33B |
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating cash flow | $7.82B | $8.67B | $8.41B | $9.15B | $9.31B |
| Capital expenditure | -$1.48B | -$1.34B | -$1.48B | -$2.24B | -$2.52B |
| Free cash flow | $6.29B | $7.27B | $6.93B | $6.91B | $6.79B |
| Dividends paid | $636.00M | $583.00M | $523.00M | $455.00M | $395.00M |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | TMO | $673.20 | +1.5% | 2.48M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Thermo Fisher Scientific Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW